Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
Publication Type:
Journal Article
Authors:
Bourliere, M.;
Bronowicki, J.;
V de Ledinghen;
Christophe Hézode;
Zoulim, F.;
Mathurin, P.;
Tran, A.;
Larrey D.G.;
Ratziu, V.;
Hyland, R.H.;
Jiang, D.;
Doehle, B.;
Pang, P.S.;
Symonds, W.T.;
Subramanian, G.M.;
McHutchison, J.G.;
P. Marcellin;
Habersetzer, F.;
Guyader, D.;
Grange, J.D.;
Loustaud-Ratti, V.;
Serfaty, L.;
Metivier, S.;
Vincent Leroy;
Abergel, A.;
Pol, S.Source:
Lancet Infect Dis., Volume 15, Issue 4, p.397-404 (2015)
